Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial

Journal of the American Academy of Dermatology

Volumn 61, Issue 2, 2009, Pages 207-215

  Weinstock, Martin A ^a,b,c   Lee, Kachiu C ^a,d   Chren, Mary Margaret ^e   Marcolivio, Kimberly ^a  

^a PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BROWN UNIVERSITY   (United States)

^c BROWN UNIVERSITY   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; RETINOIC ACID;

ACTINIC KERATOSIS; ACTINIC NEOPLASTIC SYNDROME; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMOTION; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; KERATINOCYTE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHOTOSENSITIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SKIN CARCINOMA; SKINDEX 29; SUN; SYMPTOMATOLOGY; VETERAN;

ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; CHEMOPREVENTION; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HOSPITALS, VETERANS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRECANCEROUS CONDITIONS; PROBABILITY; QUALITY OF LIFE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SKIN NEOPLASMS; TREATMENT OUTCOME; TRETINOIN;

EID: 67650177444     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.02.022     Document Type: Article

References (22)

1. Albert M.R., and Weinstock M.A. Keratinocyte carcinoma. CA Cancer J Clin 53 (2003) 292-302
2. Miller D.L., and Weinstock M.A. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 30 (1994) 774-778
3. Geller A.C., and Annas G.D. Epidemiology of melanoma and nonmelanoma skin cancer. Semin Oncol Nurs 19 (2003) 2-11
4. Lewis K.G., and Weinstock M.A. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study. Arch Dermatol 140 (2004) 837-842
5. Weinstock M.A., Bingham S.F., Lew R.A., Hall R., Eilers D., Kirsner R., et al. Topical tretinoin therapy and all-cause mortality. Arch Dermatol 145 (2009) 18-24
6. Chren M.M., Lasek R.J., Flocke S.A., and Zyzanski S.J. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 133 (1997) 1433-1440
7. Patrick D.L., and Deyo R.A. Generic and disease-specific measures in assessing health status and quality of life. Med Care 27 (1989) S217-S232
8. Clouser M.C., Harris R.B., Roe D.J., Saboda K., Ranger-Moore J., Duckett L., et al. Risk group, skin lesion history, and sun sensitivity reliability in squamous cell skin cancer progression. Cancer Epidemiol Biomarkers Prev 15 (2006) 2292-2297
9. Griffiths C.E., Wang T.S., Hamilton T.A., Voorhees J.J., and Ellis C.N. A photonumeric scale for the assessment of cutaneous photodamage. Arch Dermatol 128 (1992) 347-351
10. Lasek R.J., and Chren M.M. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol 134 (1998) 454-458
11. Christian J.B., Lapane K.L., Hume A.L., Eaton C.B., and Weinstock M.A. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial. J Natl Cancer Inst 100 (2008) 1223-1232
12. Weinstock M.A. Assessment of sun sensitivity by questionnaire: validity of items and formulation of a prediction rule. J Clin Epidemiol 45 (1992) 547-552
13. Blackford S., Roberts D., Salek M.S., and Finlay A. Basal cell carcinomas cause little handicap. Qual Life Res 5 (1996) 191-194
14. Rhee J.S., Loberiza F.R., Matthews B.A., Neuburg M., Smith T.L., and Burzynski M. Quality of life assessment in nonmelanoma cervicofacial skin cancer. Laryngoscope 113 (2003) 215-220
15. Rhee J.S., Matthews B.A., Neuburg M., Smith T.L., Burzynski M., and Nattinger A.B. Skin cancer and quality of life: assessment with the Dermatology Life Quality Index. Dermatol Surg 30 (2004) 525-529
16. Finlay A.Y., and Khan G.K. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 19 (1994) 210-216
17. Chen S.C., Bayoumi A.M., Soon S.L., Aftergut K., Cruz P., Sexton S.A., et al. A catalog of dermatology utilities: a measure of the burden of skin diseases. J Investig Dermatol Symp Proc 9 (2004) 160-168
18. Lear W., Akeroyd J.E., Mittmann N., and Murray C. Measurement of utility in nonmelanoma skin cancer. J Cutan Med Surg 12 (2008) 102-106
19. Chen T., Bertenthal D., Sahay A., Sen S., and Chren M.M. Predictors of skin-related quality of life after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma. Arch Dermatol 143 (2007) 1386-1392
20. Rhee J.S., Matthews B.A., Neuburg M., Smith T.L., Burzynski M., and Nattinger A.B. Quality of life and sun-protective behavior in patients with skin cancer. Arch Otolaryngol Head Neck Surg 130 (2004) 141-146
21. Rhee J.S., Matthews B.A., Neuburg M., Logan B.R., Burzynski M., and Nattinger A.B. The skin cancer index: clinical responsiveness and predictors of quality of life. Laryngoscope 117 (2007) 399-405
22. Cella D.F., Tulsky D.S., Gray G., Sarafian B., Linn E., Bonomi A., et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11 (1993) 570-579